Denovo Biolabels GmbH Company Profile

12:36 EDT 22nd September 2018 | BioPortfolio

Denovo Biolabels GmbHspecializes in the development of fluorescent markers for bioanalytical application




Phone: 48 251 980 2918
Fax: 49 251 980 2917

News Articles [168 Associated News Articles listed on BioPortfolio]

Denovo Licenses Previously Unknown Use of Cancer Drug for PAH

Denovo, a San Diego-Beijing precision medicine company, announced an unusual global license with the Stanford University School of Medicine to develop Denovo's own lead oncology drug for pulmonary art...

Denovo Starts US-China Phase III Study of Leukemia Treatment

Denovo Biopharma, a San Diego-Hangzhou company,  has started a pivotal Phase III trial of its lead drug, DB102 (enzastaurin). DB102, which was initially developed by Eli Lilly, failed a Phase III...

Denovo Starts US-China Phase III Study of Lymphoma Treatment

Denovo Biopharma, a San Diego-Hangzhou company,  has started a pivotal Phase III trial of its lead drug, DB102 (enzastaurin). DB102, which was initially developed by Eli Lilly, failed a Phase III...

Denovo gets IP from Stanford

Denovo Biopharma LLC received exclusive global rights to intellectual property from Stanford University School of Medicine that the company will use to develop lead compound, enzastaurin (DB102) as a ...

Denovo Biomarkers: Robert Little. Providing a novel biomarker solution to personalize drug development

Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospect...

Denovo gains IP from Stanford to develop lead program for new indication

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Alterations in the gut bacterial microbiome in fungal Keratitis patients.

Dysbiosis in the gut microbiome has been implicated in several diseases including auto-immune diseases, inflammatory diseases, cancers and mental disorders. Keratitis is an inflammatory disease of the...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Clinical Trials [53 Associated Clinical Trials listed on BioPortfolio]

Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging

Background: Painful vasoocclusive crisis (VOC) occurs in people with sickle cell disease (SCD). People with VOC have many visits to the hospital. About 10 30 percent of these people will ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Post Market Study of DeNovo NT, Natural Tissue Graft

The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human kne...

Companies [536 Associated Companies listed on BioPortfolio]

Denovo Biolabels GmbH

Denovo Biolabels GmbHspecializes in the development of fluorescent markers for bioanalytical application

Denovo Biolabels

Denovo Biolabels GmbHspecializes in the development of fluorescentmarkers for bioanalytical applications. The R&D team combinesa profound knowledge in theorganic synthesis of fluorescent dyes with ma...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

More Information about "Denovo Biolabels GmbH" on BioPortfolio

We have published hundreds of Denovo Biolabels GmbH news stories on BioPortfolio along with dozens of Denovo Biolabels GmbH Clinical Trials and PubMed Articles about Denovo Biolabels GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Denovo Biolabels GmbH Companies in our database. You can also find out about relevant Denovo Biolabels GmbH Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record